Postoperative seroma formation in breast reconstruction with latissimus dorsi flaps: A retrospective study of 174 consecutive cases

Annals of Plastic Surgery

Volumn 59, Issue 2, 2007, Pages 149-151

  Tomita, Koichi ^a   Yano, Kenji ^a,b   Masuoka, Takeshi ^a   Matsuda, Ken ^a   Takada, Akiyoshi ^a   Hosokawa, Ko ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Breast reconstruction; Donor site seroma; Latissimus dorsi flap; Risk factor

Indexed keywords

ADULT; ARTICLE; BODY MASS; BREAST RECONSTRUCTION; DATA ANALYSIS; FEMALE; HIGH RISK PATIENT; HUMAN; INCIDENCE; INVASIVE PROCEDURE; LATISSIMUS DORSI FLAP; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL RECORD REVIEW; OBESITY; ORGAN; PEROPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEROMA; SMOKING; STATISTICAL SIGNIFICANCE;

HUMANS; MAMMAPLASTY; MIDDLE AGED; SEROMA; SURGICAL FLAPS;

EID: 34547699281     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/SAP.0b013e31802c54ef     Document Type: Article

References (18)

1. Schneider WJ, Hill HL Jr, Brown RG. Latissimus dorsi myocutaneous flap for breast reconstruction. Br J Plast Surg. 1977;30:277-281.
2. Bostwick J 3rd, Vasconez LO, Jurkiewicz MJ. Breast reconstruction after a radical mastectomy. Plast Reconstr Surg. 1978;61:682-693.
3. Weinrach JC, Cronin ED, Smith BK, et al. Preventing seroma in the latissimus dorsi flap donor site with fibrin sealant. Ann Plast Surg. 2004;53:12-16.
4. Randolph LC, Barone J, Angelats J, et al. Prediction of postoperative seroma after latissimus dorsi breast reconstruction. Plast Reconstr Surg. 2005;116:1287-1290.
5. Munhoz AM, Aldrighi CM. Prediction of postoperative seroma after latissimus dorsi breast reconstruction. Plast Reconstr Surg. 2006;118:567.
6. Menke H, Erkens M, Olbrisch RR. Evolving concepts in breast reconstruction with latissimus dorsi flaps: results and follow-up of 121 consecutive patients. Ann Plast Surg. 2001;47:107-114.
7. Schwabegger A, Ninkovic M, Brenner E, et al. Seroma as a common donor site morbidity after harvesting the latissimus dorsi flap: observations on cause and prevention. Ann Plast Surg. 1997;38:594-597.
8. Delay E, Gounot N, Bouillot A, et al. Autologous latissimus breast reconstruction: a 3-year clinical experience with 100 patients. Plast Reconstr Surg. 1998;102:1461-1478.
9. Titley OG, Spyrou GE, Fatah MF. Preventing seroma in the latissimus dorsi flap donor site. Br J Plast Surg. 1997;50:106-108.
10. Akhtar S, Spyrou GE, le Fourie R. Our early experience in the use of tissue glue to reduce the incidence of seroma formation from the latissimus dorsi flap donor site. Plast Reconstr Surg. 2005;116:347-348.
11. Munhoz AM, Montag E, Fels KW, et al. Outcome analysis of breastconservation surgery and immediate latissimus dorsi flap reconstruction in patients with T1 to T2 breast cancer. Plast Reconstr Surg. 2005;116:741-752.
12. Chang DW, Youssef A, Cha S, et al. Autologous breast reconstruction with the extended latissimus dorsi flap. Plast Reconstr Surg. 2002;110:751-759; discussion 760-751.
13. Kim JY, Ross MI, Butler CE. Reconstruction following radical resection of recurrent metastatic axillary melanoma. Plast Reconstr Surg. 2006;117:1576-1583.
14. Burak WE Jr, Goodman PS, Young DC, et al. Seroma formation following axillary dissection for breast cancer: risk factors and lack of influence of bovine thrombin. J Surg Oncol. 1997;64:27-31.
15. Wilke LG, McCall LM, Posther KE, et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol. 2006;13:491-500.
16. Giuliano AE, Haigh PI, Brennan MB, et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol. 2000;18:2553-2559.
17. Burak WE, Hollenbeck ST, Zervos EE, et al. Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg. 2002;183:23-27.
18. Schrenk P, Rieger R, Shamiyeh A, et al. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer. 2000;88:608-614.